Artz, Marika A <br/><br/>
Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus.  [electronic resource] 

 -  Journal of the American Society of Nephrology : JASN  Jul 2003 
 - 1880-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1046-6673 
<br/><br/><label>Standard No.: </label>10.1097/01.asn.0000071515.27754.67  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Analysis of Variance<br/>Apolipoproteins B--blood<br/>Blood Glucose--metabolism<br/>Blood Pressure<br/>Body Weight<br/>Cardiovascular System--drug effects<br/>Cholesterol--metabolism<br/>Cyclosporine--therapeutic use<br/>Female<br/>Fibrinogen--metabolism<br/>Fibrinolysis<br/>Graft Survival<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Kidney--drug effects<br/>Kidney Transplantation<br/>Lipoproteins, LDL--metabolism<br/>Male<br/>Middle Aged<br/>Oxygen--metabolism<br/>Risk Factors<br/>Tacrolimus--therapeutic use<br/>Time Factors<br/>Triglycerides--blood